<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1185" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1185/" /><meta name="ncbi_pagename" content="DCX-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>DCX-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="DCX-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/02/07" /><meta name="citation_author" content="Ute Hehr" /><meta name="citation_author" content="Gökhan Uyanik" /><meta name="citation_author" content="Ludwig Aigner" /><meta name="citation_author" content="Sebastien Couillard-Despres" /><meta name="citation_author" content="Jürgen Winkler" /><meta name="citation_pmid" content="20301364" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1185/" /><meta name="citation_keywords" content="DCX-Related Lissencephaly" /><meta name="citation_keywords" content="DCX-Related Subcortical Band Heterotopia" /><meta name="citation_keywords" content="Neuronal migration protein doublecortin" /><meta name="citation_keywords" content="DCX" /><meta name="citation_keywords" content="DCX-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="DCX-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ute Hehr" /><meta name="DC.Contributor" content="Gökhan Uyanik" /><meta name="DC.Contributor" content="Ludwig Aigner" /><meta name="DC.Contributor" content="Sebastien Couillard-Despres" /><meta name="DC.Contributor" content="Jürgen Winkler" /><meta name="DC.Date" content="2019/02/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1185/" /><meta name="description" content="DCX-related disorders include the neuronal migration disorders:" /><meta name="og:title" content="DCX-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="DCX-related disorders include the neuronal migration disorders:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1185/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/dcx/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1185/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89558DE03FAC8100000000093403BB.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1185_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1185_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/abs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/depdc5-epilepsy/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1185_"><span class="title" itemprop="name"><i>DCX</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Ute Hehr</span>, MD, <span itemprop="author">G&#x000f6;khan Uyanik</span>, MD, <span itemprop="author">Ludwig Aigner</span>, PhD, <span itemprop="author">Sebastien Couillard-Despres</span>, PhD, and <span itemprop="author">J&#x000fc;rgen Winkler</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1185_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1185_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ute Hehr</span>, MD<div class="affiliation small">Center for Human Genetics<br />Regensburg, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.grubsneger-inu.kinilk@rheh.etu" class="oemail">ed.grubsneger-inu.kinilk@rheh.etu</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">G&#x000f6;khan Uyanik</span>, MD<div class="affiliation small">Center for Medical Genetics<br />Hanusch Hospital<br />Medical Faculty, Sigmund Freud Private University<br />Vienna, Austria<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ta.kkgw@kinayu.nahkeog" class="oemail">ta.kkgw@kinayu.nahkeog</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ta.ca.ufs.dem@kinayu.nahkeog" class="oemail">ta.ca.ufs.dem@kinayu.nahkeog</a><div></div></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ludwig Aigner</span>, PhD<div class="affiliation small">Institute of Molecular Regenerative Medicine<br />Paracelsus Medical University Salzburg<br />Salzburg, Austria<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ta.ca.ump@rengia.giwdul" class="oemail">ta.ca.ump@rengia.giwdul</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sebastien Couillard-Despres</span>, PhD<div class="affiliation small">Institute of Molecular Regenerative Medicine<br />Paracelsus Medical University Salzburg<br />Salzburg, Austria<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ta.ca.ump@serpsed-dralliuoc.s" class="oemail">ta.ca.ump@serpsed-dralliuoc.s</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">J&#x000fc;rgen Winkler</span>, MD<div class="affiliation small">Division of Molecular Neurology<br />University Hospital Erlangen<br />Erlangen, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.negnalre-ku@relkniw.negreuj" class="oemail">ed.negnalre-ku@relkniw.negreuj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 19, 2007</span>; Last Update: <span itemprop="dateModified">February 7, 2019</span>.</p><p><em>Estimated reading time: 27 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="dcx.Summary" itemprop="description"><h2 id="_dcx_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>DCX</i>-related disorders include the neuronal migration disorders:</p><ul><li class="half_rhythm"><div>Classic thick lissencephaly (more severe anteriorly), usually in males</div></li><li class="half_rhythm"><div>Subcortical band heterotopia (SBH), primarily in females</div></li></ul><p>Males with classic <i>DCX</i>-related lissencephaly typically have early and profound cognitive and language impairment, cerebral palsy, and epileptic seizures. The clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in females with SBH varies widely with cognitive abilities that range from average or mild cognitive impairment to severe intellectual disability and language impairment. Seizures, which frequently are refractory to antiepileptic medication, may be either focal or generalized and behavioral problems may also be observed.</p><p>In <i>DCX</i>-related lissencephaly and SBH the severity of the clinical manifestation correlates roughly with the degree of the underlying brain malformation as observed in cerebral imaging.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>DCX</i>-related disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Antiepileptic drugs for epileptic seizures; deep brain stimulation may improve the seizure disorder in individuals with SBH; special feeding strategies in newborns with poor suck; physical therapy to promote mobility and prevent contractures; special adaptive chairs or positioners as needed; occupational therapy to improve fine motor skills and oral-motor control; participation in speech therapy, educational training, and enrichment programs.</p><p><i>Surveillance</i>: Regular neurologic examination and monitoring of seizure activity, EEG, and antiepileptic drug levels; regular measurement of height, weight, and head circumference; evaluation of feeding and nutrition status; assessment of psychomotor, speech, and cognitive development; prompt consultation in the event of novel neurologic findings or deterioration, aspiration, or infections; monitoring for orthopedic complications such as foot deformity or scoliosis.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>DCX</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. Up to10% of unaffected mothers of children with a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are presumed to have <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> with or without <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>. A woman who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>DCX</i> pathogenic variant has a 50% chance of transmitting the pathogenic variant in each pregnancy. Hemizygous male offspring usually manifest <i>DCX</i>-related classic lissencephaly, while heterozygous female offspring may be asymptomatic or more frequently manifest a wide phenotypic spectrum of SBH. If the pathogenic variant has been identified in the family, testing to determine the genetic status of at-risk family members and prenatal testing for pregnancies at increased risk are possible.</p></div></div><div id="dcx.GeneReview_Scope"><h2 id="_dcx_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="dcx.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dcx.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>DCX</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_dcx.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Lissencephaly</div></li><li class="half_rhythm"><div>Subcortical band heterotopia</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#dcx.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="dcx.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes, see <a href="#dcx.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="dcx.Diagnosis"><h2 id="_dcx_Diagnosis_">Diagnosis</h2><p><i>DCX</i>-related disorders are <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> conditions involving abnormal neuronal migration; they include:</p><ul><li class="half_rhythm"><div>Classic lissencephaly, usually in males</div></li><li class="half_rhythm"><div>Subcortical band heterotopia (SBH), primarily in females</div></li></ul><div id="dcx.Suggestive_Findings"><h3>Suggestive Findings</h3><p>A <i>DCX</i>-related disorder <b>should be suspected</b> in individuals with characteristic findings in brain magnetic resonance imaging (MRI) in combination with epileptic seizures and/or developmental delay or behavioral problems. A family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance is an additional supportive finding.</p><div id="dcx.Brain_MRI_Findings"><h4>Brain MRI Findings</h4><p><b>Classic thick lissencephaly,</b> usually in males:</p><ul><li class="half_rhythm"><div>Is typically characterized by agyria (sulci &#x0003e;30 mm apart) or pachygyria (abnormally wide gyri with sulci 15-30 mm apart) with thickened cortex of ~10-20 mm (normal: ~4 mm) (<a class="figpopup" href="/books/NBK1185/figure/dcx.F1/?report=objectonly" target="object" rid-figpopup="figdcxF1" rid-ob="figobdcxF1">Figure 1B-C</a>) [<a class="bk_pop" href="#dcx.REF.mutch.2016.528">Mutch et al 2016</a>, DiDonato et al 2017];</div></li><li class="half_rhythm"><div>Is more severe anteriorly, referred to as an anterior-to-posterior (A&#x0003e;P) gradient;</div></li><li class="half_rhythm"><div>May be accompanied by:</div><ul><li class="half_rhythm"><div>Prominent perivascular (Virchow Robin) spaces</div></li><li class="half_rhythm"><div>Delayed myelination</div></li><li class="half_rhythm"><div>Enlarged ventricles particularly affecting the anterior horns of the lateral ventricles</div></li><li class="half_rhythm"><div>Normal or diffusely thin corpus callosum</div></li><li class="half_rhythm"><div>No obvious cerebellar or brain stem abnormalities</div></li><li class="half_rhythm"><div>Enlarged caudate head</div></li><li class="half_rhythm"><div>Mildly to moderately diminished cerebral white matter.</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figdcxF1" co-legend-rid="figlgnddcxF1"><a href="/books/NBK1185/figure/dcx.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figdcxF1" rid-ob="figobdcxF1"><img class="small-thumb" src="/books/NBK1185/bin/dcx-Image001.gif" src-large="/books/NBK1185/bin/dcx-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgnddcxF1"><h4 id="dcx.F1"><a href="/books/NBK1185/figure/dcx.F1/?report=objectonly" target="object" rid-ob="figobdcxF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Cerebral MRI of three patients with <i>DCX</i>-related disorders A. Characteristic bilateral subcortical band heterotopia (*) in a female patient with heterozygous <i>DCX</i> exon deletion</p></div></div><p><b>Subcortical band heterotopia (SBH),</b> usually in females, is characterized by one or more of the following:</p><ul><li class="half_rhythm"><div>Symmetric, usually bilateral bands of gray matter within the white matter between and parallel to the cortex and the lateral ventricles appearing as an isointense second cortical structure beneath the cortex (double cortex) and separated from the cortex by a thin layer of normal-appearing white matter. The heterotopic band is more often thick (~70%) than thin (1-7 mm) (<a class="figpopup" href="/books/NBK1185/figure/dcx.F1/?report=objectonly" target="object" rid-figpopup="figdcxF1" rid-ob="figobdcxF1">Figure 1A</a>) [<a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>, <a class="bk_pop" href="#dcx.REF.di_donato.2017.1473">Di Donato et al 2017</a>].</div></li><li class="half_rhythm"><div>Normal-appearing and/or thickened cerebral cortex with or without simplified gyration</div></li><li class="half_rhythm"><div>Predominant location in the frontoparietal lobe region</div></li></ul></div><div id="dcx.Clinical_Features"><h4>Clinical Features</h4><p>Findings may include:</p><ul><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Language impairment</div></li><li class="half_rhythm"><div>Psychomotor delay</div></li><li class="half_rhythm"><div>Behavioral disturbances</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Microcephaly</div></li></ul></div><div id="dcx.Family_History"><h4>Family History</h4><p>Evidence for <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance obtained from a detailed family history. Special attention should be paid to epilepsy, miscarriages, stillbirths, children, who died at a young age without conclusive diagnosis, and cognitive impairment or developmental delay.</p></div></div><div id="dcx.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>DCX</i>-related disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of one of the following on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1185/table/dcx.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figdcxTmoleculargenetictestingusedin" rid-ob="figobdcxTmoleculargenetictestingusedin">Table 1</a>):</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></div></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>DCX</i>-related disorders is broad, individuals with the distinctive brain MRI findings described in <a href="#dcx.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#dcx.Option_1">Option 1</a>), whereas those with insufficient clinical and imaging datain whom the diagnosis of a<i>DCX</i>-related disorder has not been considered are more likely to be diagnosed using genomic testing (see <a href="#dcx.Option_2">Option 2</a>).</p><div id="dcx.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of a <i>DCX</i>-related disorder <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>DCX</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. Typically <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications in females are not detected; however, a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> may result in <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> failure in a male. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Note: Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>DCX</i> and other genes of interest (see <a href="#dcx.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div></li><li class="half_rhythm"><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1185/table/dcx.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figdcxTmoleculargenetictestingusedin" rid-ob="figobdcxTmoleculargenetictestingusedin">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="dcx.Option_2"><h4>Option 2</h4><p>Due to phenotypic overlap with other inherited neuronal migration disorders, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option especially in the absence of sufficient clinical and imaging data. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p>Note: Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> is a common finding in <i>DCX</i>-related disorders [<a class="bk_pop" href="#dcx.REF.dagostino.2002.2507">D'Agostino et al 2002</a>, <a class="bk_pop" href="#dcx.REF.aigner.2003.329">Aigner et al 2003</a>, <a class="bk_pop" href="#dcx.REF.qu_lin.2012.367">Qu&#x000e9;lin et al 2012</a>, <a class="bk_pop" href="#dcx.REF.jamuar.2014.733">Jamuar et al 2014</a>, <a class="bk_pop" href="#dcx.REF.tsai.2016.788">Tsai et al 2016</a>, <a class="bk_pop" href="#dcx.REF.gonz_lezmor_n.2017.e0185103">Gonz&#x000e1;lez-Mor&#x000f3;n et al 2017</a>]. Sequence analysis methods, such as Sanger or <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a>, vary in their ability to detect mosaicism and should be evaluated for their detection rate. Due to assay <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a>, the proportion of <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> in both <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and parents may be underestimated. Analysis of DNA from different tissues (e.g., hair roots, buccal swabs) can be useful in the detection or confirmation of somatic mosaicism.</p><div id="dcx.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>DCX</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>DCX</i></td><td headers="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">96%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Karyotype</td><td headers="hd_h_dcx.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Single case&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="dcx.TF.1.1"><p class="no_margin">See <a href="/books/NBK1185/#dcx.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="dcx.TF.1.2"><p class="no_margin">See <a href="#dcx.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="dcx.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="dcx.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="dcx.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.matsumoto.2001.5">Matsumoto et al [2001]</a>; <a class="bk_pop" href="#dcx.REF.hoischen.2009.1673">Hoischen et al [2009]</a>; <a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al [2013]</a>; Authors, unpublished data</p></div></dd><dt>6. </dt><dd><div id="dcx.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="dcx.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.gleeson.1998.63">Gleeson et al [1998]</a> reported a balanced X:2 <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> in a female which disrupted DCX between the first two coding exons.</p></div></dd></dl></div></div></div></div></div></div><div id="dcx.Clinical_Characteristics"><h2 id="_dcx_Clinical_Characteristics_">Clinical Characteristics</h2><div id="dcx.Clinical_Description"><h3>Clinical Description</h3><p>An individual with a <i>DCX</i>-related disorder usually presents with epileptic seizures and/or developmental delay and behavioral disturbances [<a class="bk_pop" href="#dcx.REF.matsumoto.2001.5">Matsumoto et al 2001</a>, <a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>] and with the characteristic findings on brain MRI noted during clinical evaluation.</p><div id="dcx.Males"><h4>Males</h4><p><i>DCX</i>-related classic lissencephaly usually manifests with early and profound cognitive and language impairment, cerebral palsy, and epileptic seizures.</p><p><b>Development.</b> Severity of symptoms usually correlates with the degree of the underlying brain malformation observed in cerebral imaging.</p><p>Motor development is compromised, but overall better than in patients with <a href="/books/n/gene/chrom17-lis/"><i>PAFAH1B1</i>-associated classic lissencephaly</a>.</p><p><a class="bk_pop" href="#dcx.REF.leger.2008.277">Leger et al [2008]</a> reported on the development of 33 males with <i>DCX</i>-related lissencephaly:</p><ul><li class="half_rhythm"><div>At a median age of 7.5 years (range 1.5-37 years) almost half were reported to walk independently, the remaining individuals showed moderate to severe motor impairment.</div></li><li class="half_rhythm"><div>Almost half of the individuals in the study did not develop any speech.</div></li></ul><p>Behavioral disturbances may include agitation and irritability or autistic features.</p><p><b>Epileptic seizures</b> occur in more than 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and commonly start within the first year. The observed seizure pattern may include multiple seizure types, frequently with infantile spasms with or without characteristic hypsarrhythmia [<a class="bk_pop" href="#dcx.REF.leger.2008.277">Leger et al 2008</a>, <a class="bk_pop" href="#dcx.REF.dobyns.2010.5">Dobyns 2010</a>]. Seizure control remains insufficient in more than half of the affected individuals [<a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>].</p><p><b>Other findings</b></p><ul><li class="half_rhythm"><div>Disturbed muscle tone and immobility may result in contractures and scoliosis.</div></li><li class="half_rhythm"><div>More severe clinical manifestations may also affect feeding and swallowing, thus resulting in insufficient nutrition or aspiration.</div></li><li class="half_rhythm"><div>Head circumference may decline postnatally and result in postnatal microcephaly.</div></li></ul><p><b>Life span.</b> Individuals with severe classic lissencephaly may survive into adulthood. However, life span overall is shortened due to complications either directly related to the seizure disorder (including sudden unexplained death in epilepsy or in the course of a developing epileptic encephalopathy), or resulting from disturbed cerebral regulation of vital functions (e.g., breathing abnormalities) or aspiration during respiratory infections or associated with food intake.</p><p>The rare male with the milder cerebral manifestation of subcortical band heterotopia (SBH) has findings similar to those in females with SBH [<a class="bk_pop" href="#dcx.REF.dagostino.2002.2507">D'Agostino et al 2002</a>, <a class="bk_pop" href="#dcx.REF.aigner.2003.329">Aigner et al 2003</a>].</p></div><div id="dcx.Females"><h4>Females</h4><p>The SBH clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females is markedly milder than the classic lissencephaly clinical phenotype in males, very variable, and roughly correlated with the extent and thickness of the subcortical band as observed in cerebral imaging.</p><p><a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al [2013]</a> proposed two distinct subgroups among females with <i>DCX</i> pathogenic variants: a more severe clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> usually observed in <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> cases and a milder phenotype mainly observed in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> asymptomatic females with normal cerebral MRI or only thin frontal subcortical bands.</p><p>Severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with thicker SBH typically includes:</p><ul><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Moderate-to-severe intellectual disability</div></li><li class="half_rhythm"><div>Severe language impairment</div></li><li class="half_rhythm"><div>Behavioral problems</div></li><li class="half_rhythm"><div>Seizures (frequently refractory to antiepileptic medication) that may be either focal or generalized (~50% each) and in more severe cases eventually progress to Lennox-Gastaut syndrome [<a class="bk_pop" href="#dcx.REF.dobyns.2010.5">Dobyns 2010</a>]</div></li></ul><p>Mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with thin frontal band heterotopia or normal-appearing cerebral MRI may include:</p><ul><li class="half_rhythm"><div>Average or mildly impaired cognitive skills [<a class="bk_pop" href="#dcx.REF.guerrini.2003.30">Guerrini et al 2003</a>]</div></li><li class="half_rhythm"><div>No additional symptoms</div></li><li class="half_rhythm"><div>Recognition only after prenatal or postnatal diagnosis of a <i>DCX</i>-related disorder in an offspring or other family member</div></li></ul><p>As in other <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders, <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> has been postulated to contribute to inter- and intrafamilial phenotypic variability in females <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. As an example, such variability has been observed in monozygous female twins heterozygous for a recurrent <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant [<a class="bk_pop" href="#dcx.REF.martin.2004.108">Martin et al 2004</a>]. Both twins had thick generalized SBH, clearly delineated from the cortex by a small band of white matter. However, one twin had a broader heterotopic band than the other including frontal pachygyria associated with more profound cognitive and psychomotor impairment and a more abnormal EEG than observed in her twin sister.</p></div><div id="dcx.Somatic_Mosaicism"><h4>Somatic Mosaicism</h4><p>Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for <i>DCX</i> pathogenic variants has been repeatedly documented in both females and males with milder manifestations [<a class="bk_pop" href="#dcx.REF.dagostino.2002.2507">D'Agostino et al 2002</a>, <a class="bk_pop" href="#dcx.REF.aigner.2003.329">Aigner et al 2003</a>, <a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>, <a class="bk_pop" href="#dcx.REF.jamuar.2014.733">Jamuar et al 2014</a>].</p></div><div id="dcx.Pathophysiology"><h4>Pathophysiology</h4><p>In <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> males all neurons express the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and are disturbed in their migratory properties, leading to the smoothened and disorganized thickened cortex observed in classic lissencephaly.</p><p>In females <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, inactivation of one of the two X chromosomes in neural/somatic cells is thought to result in two neuronal populations [<a class="bk_pop" href="#dcx.REF.forman.2005.847">Forman et al 2005</a>, <a class="bk_pop" href="#dcx.REF.marcorelles.2010.503">Marcorelles et al 2010</a>, <a class="bk_pop" href="#dcx.REF.wynshawboris.2010.823">Wynshaw-Boris et al 2010</a>]:</p><ul><li class="half_rhythm"><div>Cells expressing the wild type <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> that continue and complete their migratory process to form the normal cortex</div></li><li class="half_rhythm"><div>Cells expressing the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that accumulate in the white matter between the cortex and lateral ventricles as a heterotopic band of neurons</div></li></ul></div></div><div id="dcx.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>About one third of all <i>DCX</i> pathogenic variants are recurrent, resulting in rather similar <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>-specific cortical phenotypes in and between families [<a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>].</p><p>A slight effect of the type and location of the <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the resulting severity of the brain malformation for both SBH and classic lissencephaly has been suggested [<a class="bk_pop" href="#dcx.REF.leventer.2005.307">Leventer 2005</a>, <a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>].</p><ul><li class="half_rhythm"><div><i>DCX</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants in males are very rare and have mainly been observed as postzygotic mosaic events.</div></li><li class="half_rhythm"><div>Loss-of-function variants are more likely to occur in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family); <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are more likely to be observed in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases [<a class="bk_pop" href="#dcx.REF.gleeson.1999.146">Gleeson et al 1999</a>, <a class="bk_pop" href="#dcx.REF.leger.2008.277">Leger et al 2008</a>, <a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>].</div></li><li class="half_rhythm"><div>Hemizygous <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants within the N-terminal DC tandem repeat <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> tend to result in more severe forms of lissencephaly than missense variants in the C-DC domain.</div></li><li class="half_rhythm"><div>Truncating variants were more frequently associated with generalized subcortical bands; <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants were more commonly associated with frontal band heterotopia only [<a class="bk_pop" href="#dcx.REF.matsumoto.2001.5">Matsumoto et al 2001</a>, <a class="bk_pop" href="#dcx.REF.leventer.2005.307">Leventer 2005</a>, <a class="bk_pop" href="#dcx.REF.leger.2008.277">Leger et al 2008</a>, <a class="bk_pop" href="#dcx.REF.haverfield.2009.911">Haverfield et al 2009</a>].</div></li><li class="half_rhythm"><div><i>DCX</i>-related SBH in males appears to result predominantly from either <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or specific <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants with residual function [<a class="bk_pop" href="#dcx.REF.leger.2008.277">Leger et al 2008</a>].</div></li></ul><p>For further information on postulated functional consequences of various <i>DCX</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and the observed clinical manifestations in male and female patients see <a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al [2013]</a>.</p></div><div id="dcx.Penetrance"><h3>Penetrance</h3><p><b>Males</b></p><ul><li class="half_rhythm"><div>No instances of asymptomatic males with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>DCX</i> pathogenic variants have been reported, thus suggesting full <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of germline <i>DCX</i> pathogenic variants in males.</div></li><li class="half_rhythm"><div>Males with postzygotic mosaic pathogenic variants may have milder clinical manifestations or, in rare cases, be asymptomatic (see Clinical Description, <a href="#dcx.Somatic_Mosaicism">Somatic Mosaicism</a>).</div></li></ul><p><b>Females</b></p><ul><li class="half_rhythm"><div>Heterozygous females with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> <i>DCX</i> variants may have no obvious brain malformation or seizures [<a class="bk_pop" href="#dcx.REF.aigner.2003.329">Aigner et al 2003</a>, <a class="bk_pop" href="#dcx.REF.guerrini.2003.30">Guerrini et al 2003</a>].</div></li><li class="half_rhythm"><div>Penetrance was reported to be less than 50% in the mothers with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or mosaic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>DCX</i> whose children presented with <i>DCX</i>-related disorders [<a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>].</div></li></ul></div><div id="dcx.Nomenclature"><h3>Nomenclature</h3><p>Classic lissencephaly may also be called lissencephaly type 1. In the absence of associated intra- or extracranial malformations it is also termed <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> lissencephaly sequence.</p><p>Classic lissencephaly that occurs in combination with cerebellar hypoplasia is classified as lissencephaly with cerebellar hypoplasia.</p><p>Classic lissencephaly is morphologically and etiologically distinct from lissencephaly type 2, which is also called cobblestone lissencephaly, and from thin lissencephaly.</p><p>To emphasize their <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance, <i>DCX</i>-related lissencephaly and SBH have variably been termed and abbreviated:</p><ul><li class="half_rhythm"><div><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> lissencephaly (XLIS)</div></li><li class="half_rhythm"><div>Lissencephaly, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> (LISX)</div></li><li class="half_rhythm"><div>Isolated lissencephaly, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> (ILSX)</div></li><li class="half_rhythm"><div>Subcortical laminar heterotopia, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> (X-SCLH)</div></li><li class="half_rhythm"><div>Subcortical band heterotopia, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> (SBHX)</div></li></ul><p><i>DCX</i>-related lissencephaly and SBH have also been referred to as double cortex syndrome.</p></div><div id="dcx.Prevalence"><h3>Prevalence</h3><p>The incidence of all forms of type 1 lissencephaly has been estimated at 1:100,000 births [<a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&#x00026;Expert=48471" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Orphanet</a>], with the majority resulting from <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants of <i>PAFAH1B1</i> (<i>LIS1</i>). No specific data on the prevalence of lissencephaly due to pathogenic variants in <i>DCX</i> are available.</p><p><i>DCX-</i>related disorders account for:</p><ul><li class="half_rhythm"><div>Virtually all families with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance of classic lissencephaly and/or SBH;</div></li><li class="half_rhythm"><div>About 10% of all persons with classic lissencephaly (38% of all males, but only rare females);</div></li><li class="half_rhythm"><div>About 53%-85% of all SBH, about 80% of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> SBH, and about 29% of SBH in males [<a class="bk_pop" href="#dcx.REF.pilz.1998.2029">Pilz et al 1998</a>, <a class="bk_pop" href="#dcx.REF.gleeson.1999.146">Gleeson et al 1999</a>, <a class="bk_pop" href="#dcx.REF.matsumoto.2001.5">Matsumoto et al 2001</a>, <a class="bk_pop" href="#dcx.REF.guerrini.2005.287">Guerrini &#x00026; Filippi 2005</a>].</div></li></ul></div></div><div id="dcx.Genetically_Related_Allelic_Disorder"><h2 id="_dcx_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>DCX.</i></p></div><div id="dcx.Differential_Diagnosis"><h2 id="_dcx_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a class="figpopup" href="/books/NBK1185/table/dcx.T.disorders_with_lissencephalypachyg/?report=objectonly" target="object" rid-figpopup="figdcxTdisorderswithlissencephalypachyg" rid-ob="figobdcxTdisorderswithlissencephalypachyg">Tables 2a</a>, <a class="figpopup" href="/books/NBK1185/table/dcx.T.disorders_with_lissencephalypachyg_1/?report=objectonly" target="object" rid-figpopup="figdcxTdisorderswithlissencephalypachyg1" rid-ob="figobdcxTdisorderswithlissencephalypachyg1">2b</a>, and <a class="figpopup" href="/books/NBK1185/table/dcx.T.disorders_with_subcortical_band_he/?report=objectonly" target="object" rid-figpopup="figdcxTdisorderswithsubcorticalbandhe" rid-ob="figobdcxTdisorderswithsubcorticalbandhe">2c</a> for disorders to consider in the differential diagnosis of <i>DCX</i>-related disorders.</p><div id="dcx.T.disorders_with_lissencephalypachyg" class="table"><h3><span class="label">Table 2a. </span></h3><div class="caption"><p>Disorders with Lissencephaly-Pachygyria with Classic or Thick Lissencephaly (cortex 10-20 mm) to Consider in the Differential Diagnosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.T.disorders_with_lissencephalypachyg/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.T.disorders_with_lissencephalypachyg_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Features Differentiating This Disorder from <i>DCX</i> Disorders</th></tr></thead><tbody><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/chrom17-lis/"><i>PAFAH1B1</i>-</a><br /><a href="/books/n/gene/chrom17-lis/">associated</a><br /><a href="/books/n/gene/chrom17-lis/">lissencephaly</a></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PAFAH1B1</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Most frequent cause of classic or thick lissencephaly</div></li><li class="half_rhythm"><div>More prominent in the posterior regions of the brain, w/a P&#x0003e;A gradient</div><div>(<i>DCX</i>-related lissencephaly presents w/an A&#x0003e;P gradient.)&#x000a0;<sup>1</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/chrom17-lis/">Miller-Dieker</a><br /><a href="/books/n/gene/chrom17-lis/">syndrome</a></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microdeletion<br />of 17p13.3&#x000a0;<sup>2</sup></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Distinctive facial features (i.e., prominent forehead, bitemporal hollowing, short nose w/upturned tip &#x00026; anteverted nostrils, &#x00026; protuberant upper lip w/thin vermilion border)</div></li><li class="half_rhythm"><div>Cardiac malformations &#x00026; omphalocele also reported as rare associated extracerebral manifestations&#x000a0;<sup>3</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBA1A</i>-<br />related<br />lissencephaly<br />(see<br /><a href="/books/n/gene/tubulin-ov/">Tubulinopathies Overview</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBA1A</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Tubulinopathy-related dysgyria as more complex cortical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> including areas w/polymicrogyria-like appearance or simplified gyral pattern</div></li><li class="half_rhythm"><div>Small brain stem, cerebellar vermis &#x00026;/or cerebellar hemispheres, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> or absent corpus callosum, anterior limb of the capsula interna not delineated, large tectum&#x000a0;<sup>4</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DYNC1H1</i>-<br />related<br />pachygyria<br />(OMIM <a href="https://omim.org/entry/614563" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614563</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DYNC1H1</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior or anterior predominant pachygyria or dysgyria&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KIF5C</i>-related<br />pachygyria<br />(OMIM <a href="https://omim.org/entry/615282" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615282</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KIF5C</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Posterior or anterior predominant pachygyria</div></li><li class="half_rhythm"><div>Severe intrauterine growth retardation</div></li><li class="half_rhythm"><div>Arthrogryposis</div></li><li class="half_rhythm"><div>Microcephaly&#x000a0;<sup>5</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baraitser-<br />Winter<br />syndrome<br />(OMIM<br /><a href="https://omim.org/phenotypicSeries/PS243310" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS243310</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACTB</i><br /><i>ACTG1</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Thick cortex anterior or central predominant or SBH</div></li><li class="half_rhythm"><div>Dysmorphic features</div></li><li class="half_rhythm"><div>Iris or retinal coloboma</div></li><li class="half_rhythm"><div>Sensoneurinal deafness</div></li><li class="half_rhythm"><div>Congenital cardiac or renal malformations</div></li><li class="half_rhythm"><div>Abnormal corpus callosum (short, thick or absent)&#x000a0;<sup>6</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDK5</i>-related<br />lissencephaly<br />(OMIM<br /><a href="https://omim.org/entry/616342" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616342</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDK5</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Agyria</div></li><li class="half_rhythm"><div>Agenesis of the corpus callosum</div></li><li class="half_rhythm"><div>Severe cerebellar &#x00026; pontine hypoplasia</div></li><li class="half_rhythm"><div>Dilated subarachnoidal spaces</div></li><li class="half_rhythm"><div>Dysmorphic facial features, lymphedema, arthrogryposis multiplex</div></li><li class="half_rhythm"><div>Early lethal&#x000a0;<sup>7</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">A = anterior; AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; P = posterior; SBH = subcortical band heterotopia</p></div></dd><dt>1. </dt><dd><div id="dcx.TF.2a.1"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.uyanik.2007.442">Uyanik et al [2007]</a></p></div></dd><dt>2. </dt><dd><div id="dcx.TF.2a.2"><p class="no_margin">Miller-Dieker syndrome is caused by either small cytogenetically visible deletions or <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>-detectable microdeletions of 17p13.3 that include <i>LIS1</i> (officially designated as <i>PAFAH1B1</i>) and <i>YWHAE</i>, and intervening genes.</p></div></dd><dt>3. </dt><dd><div id="dcx.TF.2a.3"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.bruno.2010.299">Bruno et al [2010]</a></p></div></dd><dt>4. </dt><dd><div id="dcx.TF.2a.4"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.bahibuisson.2014.1676">Bahi-Buisson et al [2014]</a></p></div></dd><dt>5. </dt><dd><div id="dcx.TF.2a.5"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.poirier.2013.639">Poirier et al [2013]</a></p></div></dd><dt>6. </dt><dd><div id="dcx.TF.2a.6"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.di_donato.2016a.1117">Di Donato et al [2016a]</a>, <a class="bk_pop" href="#dcx.REF.di_donato.2016b.2644">Di Donato et al [2016b]</a></p></div></dd><dt>7. </dt><dd><div id="dcx.TF.2a.7"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.magen.2015.305">Magen et al [2015]</a></p></div></dd></dl></div></div></div><div id="dcx.T.disorders_with_lissencephalypachyg_1" class="table"><h3><span class="label">Table 2b. </span></h3><div class="caption"><p>Disorders with Lissencephaly-Pachygyria with Thin Lissencephaly (cortex 5-10 mm) to Consider in the Differential Diagnosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.T.disorders_with_lissencephalypachyg_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.T.disorders_with_lissencephalypachyg_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Features Differentiating This Disorder from <i>DCX</i> Disorders</th></tr></thead><tbody><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a><br />lissencephaly<br />w/ambiguous<br />genitalia<br />(OMIM<br /><a href="https://omim.org/entry/300215" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300215</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARX</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Temporal predominant thin lissencephaly (6-10 mm)</div></li><li class="half_rhythm"><div>Agenesis of the corpus callosum</div></li><li class="half_rhythm"><div>Perinatal encephalopathy w/intractable seizures</div></li><li class="half_rhythm"><div>Brain stem &#x00026; cerebellum appear normal</div></li><li class="half_rhythm"><div>Ambiguous or underdeveloped genitalia</div></li><li class="half_rhythm"><div>Chronic diarrhea</div></li><li class="half_rhythm"><div>High lethality in 1st 3 mos of life&#x000a0;<sup>1</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RELN</i>-related<br />lissencephaly<br />(OMIM<br /><a href="https://omim.org/entry/257320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">257320</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RELN</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Thin lissencephaly w/A&#x0003e;P gradient</div></li><li class="half_rhythm"><div>Severe cerebellar hypoplasia&#x000a0;<sup>2</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/vldlr-ch/"><i>VLDLR-</i></a><br /><a href="/books/n/gene/vldlr-ch/">associated</a><br /><a href="/books/n/gene/vldlr-ch/">cerebellar</a><br /><a href="/books/n/gene/vldlr-ch/">hypoplasia</a></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VLDLR</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Thin lissencephaly w/A&#x0003e;P gradient</div></li><li class="half_rhythm"><div>Severe cerebellar hypoplasia&#x000a0;<sup>2</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CRADD</i><br />related<br />lissencephaly<br />(OMIM<br /><a href="https://omim.org/entry/614499" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614499</a>)</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CRADD</i></td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dcx.T.disorders_with_lissencephalypachyg_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Anterior predominant thin lissencephaly</div></li><li class="half_rhythm"><div>Megalencephaly</div></li><li class="half_rhythm"><div>Normal cerebellum&#x000a0;<sup>3</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">A = anterior; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; P = posterior; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="dcx.TF.2b.1"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.uyanik.2003.232">Uyanik et al [2003]</a>, <a class="bk_pop" href="#dcx.REF.coman.2017">Coman et al [2017]</a></p></div></dd><dt>2. </dt><dd><div id="dcx.TF.2b.2"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.valence.2016.545">Valence et al [2016]</a></p></div></dd><dt>3. </dt><dd><div id="dcx.TF.2b.3"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.di_donato.2016a.1117">Di Donato et al [2016a]</a>, <a class="bk_pop" href="#dcx.REF.di_donato.2016b.2644">Di Donato et al [2016b]</a></p></div></dd></dl></div></div></div><div id="dcx.T.disorders_with_subcortical_band_he" class="table"><h3><span class="label">Table 2c. </span></h3><div class="caption"><p>Disorders with Subcortical Band Heterotopia to Consider in the Differential Diagnosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.T.disorders_with_subcortical_band_he/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.T.disorders_with_subcortical_band_he_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Features Differentiating This Disorder from <i>DCX</i> Disorders</th></tr></thead><tbody><tr><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/chrom17-lis/"><i>PAFAH1B1</i>-</a><br /><a href="/books/n/gene/chrom17-lis/">associated</a><br /><a href="/books/n/gene/chrom17-lis/">subcortical</a><br /><a href="/books/n/gene/chrom17-lis/">band</a><br /><a href="/books/n/gene/chrom17-lis/">heterotopia</a></td><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PAFAH1B1</i></td><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">More prominent in the posterior regions of the brain, w/a P&#x0003e;A gradient<br />(<i>DCX</i>-related SBH presents w/an A&#x0003e;P gradient.)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baraitser-<br />Winter<br />syndrome<br />(OMIM<br /><a href="http://www.omim.org/entry/243310" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">243310</a>,<br /><a href="http://www.omim.org/entry/614583" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614583</a>)</td><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACTB</i><br /><i>ACTG1</i></td><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dcx.T.disorders_with_subcortical_band_he_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short central regions of SBH adjacent to frontal pachygyria</div></li><li class="half_rhythm"><div>Dysmorphic features</div></li><li class="half_rhythm"><div>Iris or retinal coloboma</div></li><li class="half_rhythm"><div>Sensoneurinal deafness</div></li><li class="half_rhythm"><div>Congenital cardiac or renal malformations</div></li><li class="half_rhythm"><div>Abnormal corpus callosum (short; thick or absent)&#x000a0;<sup>2</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">A = anterior; AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; P = posterior; SBH = subcortical band heterotopia</p></div></dd><dt>1. </dt><dd><div id="dcx.TF.2c.1"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.uyanik.2007.442">Uyanik et al [2007]</a></p></div></dd><dt>2. </dt><dd><div id="dcx.TF.2c.2"><p class="no_margin"><a class="bk_pop" href="#dcx.REF.di_donato.2016a.1117">Di Donato et al [2016a]</a>, <a class="bk_pop" href="#dcx.REF.di_donato.2016b.2644">Di Donato et al [2016b]</a></p></div></dd></dl></div></div></div><p><b>Other disorders to consider</b> include those with cobblestone lissencephaly (i.e., Walker-Warburg syndrome, muscle eye brain disease [see OMIM <a href="https://omim.org/phenotypicSeries/PS236670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS236670</a>], and <a href="/books/n/gene/fcmd/">Fukuyama congenital muscular dystrophy</a>) as well as tubulinopathies (see <a href="/books/n/gene/tubulin-ov/">Tubulinopathies Overview</a>), disorders with polymicrogyria, and disorders with periventricular nodular heterotopia (see <a href="/books/n/gene/x-pvh/"><i>FLNA</i>-Related Periventricular Nodular Heterotopia</a>).</p></div><div id="dcx.Management"><h2 id="_dcx_Management_">Management</h2><div id="dcx.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the individual clinical manifestation of a <i>DCX</i>-related disorder, the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Neurologic evaluation, including EEG and cerebral MRI. This is best performed by a pediatric neurologist or neurologist with special expertise in the diagnosis, treatment, and surveillance of individuals with multiple disabilities and difficult-to-treat seizures</div></li><li class="half_rhythm"><div>Developmental evaluation including motor skills, cognition, and speech</div></li><li class="half_rhythm"><div>Growth and head circumference</div></li><li class="half_rhythm"><div>Nutrition and feeding evaluation (including a swallowing assessment in individuals lacking head control or the ability to sit unsupported) to enable early recognition of malnutrition or risk constellations for aspiration that would require special medical surveillance or measures (e.g., tube feeding)</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation for impaired vision, potentially correctable by glasses</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="dcx.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Epileptic seizures require antiepileptic medication. Individual treatment strategies should be based on the type and frequency of seizures, EEG results, and responsiveness.</p><p>Surgical resection of heterotopic brain tissue has been tried in only a few individuals with SBH; overall it has not been effective in reducing seizure activity and thus is not recommended [<a class="bk_pop" href="#dcx.REF.bernasconi.2001.1124">Bernasconi et al 2001</a>]. More recently, deep brain stimulation has been suggested to improve the seizure disorder in individuals with SBH based on first results in small treated cohorts [<a class="bk_pop" href="#dcx.REF.franco.2016.426">Franco et al 2016</a>].</p><p>In addition, appropriate interdisciplinary management should start at the time of diagnosis and can prolong survival and improve quality of life for individuals with a <i>DCX</i>-related disorder:</p><ul><li class="half_rhythm"><div>Feeding problems in newborns may require special strategies including placement of a percutaneous endoscopic gastrostomy tube to deal with weak or uncoordinated sucking.</div></li><li class="half_rhythm"><div>Physical therapy helps to maintain and promote mobility and prevent contractures. Special adaptive chairs or positioners or other measures may support sitting and mobility.</div></li><li class="half_rhythm"><div>Occupational therapy may help improve fine motor skills and oral motor control.</div></li><li class="half_rhythm"><div>Speech therapy may improve communication</div></li><li class="half_rhythm"><div>A full range of educational training and enrichment programs should be available.</div></li><li class="half_rhythm"><div>Parents should be informed early and repeatedly on the common presentation and appropriate management of seizures. For parents of individuals with a severe manifestation of a <i>DCX</i>-related disorder this should also include appropriate discussion of the level of care in sudden critical situations.</div></li><li class="half_rhythm"><div>For information on non-medical interventions and coping strategies for parents or caregivers of children with seizure disorders see <a href="https://www.cdc.gov/epilepsy/toolkit/index.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</div></li></ul></div><div id="dcx.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Adequate antiepileptic treatment is important to reduce the number of seizures, which may be associated with irreversible and life-threatening complications.</p></div><div id="dcx.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Regular neuropediatric or neurologic examination including monitoring of seizure activity, EEG, and antiepileptic drug (AED) levels</div></li><li class="half_rhythm"><div>Regular measurement of height, weight, and head circumference; evaluation of feeding and nutrition status; assessment of psychomotor, speech, and cognitive development</div></li><li class="half_rhythm"><div>Prompt neuropediatric, neurologic, or pediatric consultation in the event of novel neurologic findings or deterioration, aspiration, or infections</div></li><li class="half_rhythm"><div>Monitoring of orthopedic complications including foot deformity and scoliosis</div></li></ul></div><div id="dcx.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#dcx.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="dcx.Pregnancy_Management"><h3>Pregnancy Management</h3><p>For pregnant women with <i>DCX</i>-related SBH and known history of seizures or current epileptic seizures, close medical surveillance by a neurologist familiar with the treatment of seizures (preferably at an epilepsy center) is recommended.</p><p>Counseling should include discussion of the teratogenic risks associated with the currently used antiepileptic medication. For some antiepileptic medications or their combination, a substantially increased risk for fetal malformations may prompt reconsideration of the dosage or drug combination. Pregnant women should, however, be encouraged to continue medical seizure control under close surveillance and be informed about the risks associated with discontinuation of treatment.</p><p>Counseling should also cover the preferred mode of delivery based on the current neurologic findings as well as any recommended postnatal measures for the newborn related to fetal medication exposure and its postnatal drop.</p><p>Whenever possible, women should discuss the current antiepileptic medication or any recommended replacement of medication with higher teratogenic potential prior to any planned pregnancy.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="dcx.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="dcx.Genetic_Counseling"><h2 id="_dcx_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="dcx.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>DCX</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="dcx.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>A female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have the disorder as the result of a <i>de novo DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or have inherited a <i>DCX</i> pathogenic variant from:</div><ul><li class="half_rhythm"><div>An asymptomatic or only mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother; about half of identified <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> mothers appear clinically unaffected [<a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>]; asymptomatic heterozygous females without obvious structural changes of the brain have been reported [<a class="bk_pop" href="#dcx.REF.demelas.2001.327">Demelas et al 2001</a>, <a class="bk_pop" href="#dcx.REF.aigner.2003.329">Aigner et al 2003</a>].</div></li><li class="half_rhythm"><div>An asymptomatic or mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> father with somatic and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#dcx.REF.moreira.2015.62">Moreira et al 2015</a>].</div></li></ul></li><li class="half_rhythm"><div>A male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may either have the disorder as the result of a <i>de novo DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or have inherited the <i>DCX</i> pathogenic variant from an asymptomatic or only mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother. Note: The father of an affected male will not have the disorder nor will he have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> or be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>DCX</i> pathogenic variant; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>The parents of approximately 90% of female probands and 25% of male probands are clinically unaffected. The <i>DCX</i> pathogenic variants in these probands may be either <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or inherited from an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or mosaic parent.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male either is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or &#x02013; if the <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA and she has more than one affected child and no other affected relatives &#x02013; she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Preliminary data suggest that as many as 10% of unaffected mothers of probands with a <i>DCX</i> pathogenic variant may have germline mosaicism with or without <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> [<a class="bk_pop" href="#dcx.REF.gleeson.2000.574">Gleeson et al 2000</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing of the mother for the <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in a male or female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is recommended. If the <i>DCX</i> pathogenic variant is not identified in maternal leukocyte DNA, additional maternal tissues (e.g., buccal swabs) may be examined for the <i>DCX</i> pathogenic variant identified in her offspring. In addition, the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> could be assessed by neurologic and/or clinical examination of the mother and brain MRI to search for subcortical band heterotopia (SBH).</div></li><li class="half_rhythm"><div>If the <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not identified in her mother, genetic testing (with sufficient <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> to uncover rare paternal <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>) of paternal leukocyte DNA and additional paternal tissues for the <i>DCX</i> pathogenic variant may be considered.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the clinical/genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s mother is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting the <i>DCX</i> pathogenic variant in each pregnancy is 50%.</div><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will usually be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with <i>DCX</i>-related classic lissencephaly.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and will be at high risk of developing the variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with SBH.</div></li></ul></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a>/<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>DCX</i> pathogenic cannot be detected in maternal leukocyte DNA:</div><ul><li class="half_rhythm"><div>Recurrence risk to sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has been estimated between 5%-10% because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, mainly in the mother [<a class="bk_pop" href="#dcx.REF.gleeson.2000.574">Gleeson et al 2000</a>, <a class="bk_pop" href="#dcx.REF.guerrini.2005.287">Guerrini &#x00026; Filippi 2005</a>].</div></li><li class="half_rhythm"><div>Recurrence risk to sibs is also slightly increased by the possibility of paternal transmission of a <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from an asymptomatic or mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> father with somatic and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#dcx.REF.moreira.2015.62">Moreira et al 2015</a>].</div></li></ul></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> due to a postzygotic event is suggested based on molecular genetic laboratory results in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> presenting a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case, sibs would not be considered at increased risk.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Males with classic lissencephaly are usually severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and are not known to reproduce; to date, no instances of offspring have been reported.</div></li><li class="half_rhythm"><div>Females with a <i>DCX</i>-related disorder have a 50% chance of transmitting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to each child:</div><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will usually be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with <i>DCX</i>-related classic lissencephaly.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and will be at high risk of developing the variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with SBH.</div></li></ul></li><li class="half_rhythm"><div>For male or female probands with mild disease forms resulting from <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for <i>DCX</i> pathogenic variants(e.g., SBH in males), <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> depends on the proportion of germ cells with the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and may be as high as the formal risk assumed for the offspring of individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or, theoretically, <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the pathogenic variant [<a class="bk_pop" href="#dcx.REF.moreira.2015.62">Moreira et al 2015</a>].</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal grandmother and maternal aunts are at higher risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The offspring of heterozygous females have a 50% chance of being heterozygous or <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a>, depending on their gender, for the <i>DCX</i> pathogenic variant and developing the respective <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Note: Molecular genetic testing may be able to identify the family member in whom a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> arose &#x02013; information that could help determine genetic risk status of the extended family.</p></div><div id="dcx.Heterozygote_Detection_in_Asymptomat"><h3>Heterozygote Detection in Asymptomatic Females</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Note: (1) Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder or have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> may be clinically unaffected or may present with a wide range of clinical manifestations. (2) Identification of heterozygous females requires either (a) prior identification of the <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family or, (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and if no pathogenic variant is identified, by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div><div id="dcx.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b><a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>.</b> As in other <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders, X-chromosome inactivation may further significantly contribute to a wide inter- and intrafamilial phenotypic variability in females <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. However, data obtained from a peripheral blood sample may not represent the proportion of cells with the active mutated <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in other tissues. Furthermore, testing for skewed X-chromosome inactivation in any available pre- or postnatal sample is of no value in predicting the clinical manifestations of a heterozygous <i>DCX</i> pathogenic variant in any individual.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, or are at risk of being heterozygous.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="dcx.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible. Accurate prediction of the expected clinical manifestations in a female fetus prenatally diagnosed as <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>DCX</i> pathogenic variant is not possible. Therefore, prenatal testing of a female fetus should be offered only after thorough discussion with the expecting parents regarding the reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and wide phenotypic variability in females heterozygous for a <i>DCX</i> pathogenic variant.</p><p><b>Fetal ultrasonography/MRI.</b> During fetal development first gyri appear around the 20th week of gestation, and a reduced gyration pattern (compared to postnatal images) remains physiologic until late gestation. Therefore, in the absence of a positive family history, <i>DCX</i>-related classic lissencephaly may not be recognized even during late gestation by fetal sonography; SBH, in most cases, will not be recognized until birth. However, occasional detection of SBH or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> lissencephaly by fetal MRI and/or ultrasound examination at later stages of gestation has been reported [<a class="bk_pop" href="#dcx.REF.ghai.2006.389">Ghai et al 2006</a>].</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p></div></div><div id="dcx.Resources"><h2 id="_dcx_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Association on Intellectual and Developmental Disabilities (AAIDD)</b></div><div>501 3rd Street Northwest</div><div>Suite 200</div><div>Washington DC 20001</div><div><b>Phone:</b> 202-387-1968</div><div><b>Fax:</b> 202-387-2193</div><div><b>Email:</b> sis@aaidd.org</div><div><a href="http://www.aaidd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aaidd.org</a></div></li><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>LISS e.V.</b></div><div>Anlaufstelle f&#x000fc;r Eltern &#x00026; Angeh&#x000f6;rige an Lissenzephalie leidender Kinder e.V.</div><div>Eissendorfer Pferdeweg 12a</div><div> Hamburg 21075</div><div>Germany</div><div><a href="http://lissenzephalie.de/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lissenzephalie.de</a></div></li><li class="half_rhythm"><div><b>The Lissencephaly Network, Inc</b></div><div>1549 Regent Street</div><div>Regina Saskatchewan S4N 1S1</div><div>Canada</div><div><b>Phone:</b> 306-569-0146</div></li></ul></div><div id="dcx.Molecular_Genetics"><h2 id="_dcx_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="dcx.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>DCX-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_dcx.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_dcx.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_dcx.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_dcx.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_dcx.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_dcx.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_dcx.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1641" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DCX</i></a></td><td headers="hd_b_dcx.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1641" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq23</a></td><td headers="hd_b_dcx.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O43602" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neuronal migration protein doublecortin</a></td><td headers="hd_b_dcx.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/DCX" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DCX database</a></td><td headers="hd_b_dcx.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DCX" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DCX</a></td><td headers="hd_b_dcx.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DCX[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DCX</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="dcx.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="dcx.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for DCX-Related Disorders (<a href="/omim/300067,300121" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300067" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300067</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LISSENCEPHALY, X-LINKED, 1; LISX1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300121" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300121</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DOUBLECORTIN; DCX</td></tr></tbody></table></div></div><div id="dcx.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>DCX</i> shares homology with a group of genes that have a conserved doublecortin (DC) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> comprising two tandemly repeated 80-amino acid regions (pep1 and pep2) [<a class="bk_pop" href="#dcx.REF.sapir.2000.703">Sapir et al 2000</a>, <a class="bk_pop" href="#dcx.REF.taylor.2000.34442">Taylor et al 2000</a>]. This <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> family comprises eleven paralogs in human and in mouse and includes genes such as <i>RP1</i> (OMIM <a href="http://www.omim.org/entry/603937" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">603937</a>), associated with a form of <a href="/books/n/gene/rp-overview/">retinitis pigmentosa</a>, and <i>DCDC2</i> (OMIM <a href="http://www.omim.org/entry/605755" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605755</a>), associated with dyslexia [<a class="bk_pop" href="#dcx.REF.reiner.2006.188">Reiner et al 2006</a>].</p><p><b>Gene structure.</b>
<i>DCX</i> spans 118 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA and comprises nine exons including the coding exons 2-7; alternatively spliced exons 1a, 1b, and 1c are untranslated [<a class="bk_pop" href="#dcx.REF.des_portes.1998.51">des Portes et al 1998</a>]. <i>DCX</i> transcripts include:</p><ul><li class="half_rhythm"><div>NM_178153.2; DCX-203 (<a href="https://www.ensembl.org/Homo_sapiens/Transcript/Exons?db=core;g=ENSG00000077279;r=X:111293779-111412429;t=ENST00000371993" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000371993.6</a>) &#x02013; the main isoform; comprising 7 exons including the untranslated <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1b;</div></li><li class="half_rhythm"><div><a href="/nuccore/NM_001195553" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001195553</a> &#x02013; alternative transcript with 18-bp (6-amino acid) <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> between exons 5 and 6 and 3-bp (1-amino acid) insertion between exons 6 and 7 [<a class="bk_pop" href="#dcx.REF.gleeson.1998.63">Gleeson et al 1998</a>].</div></li></ul><p>For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1185/#dcx.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Disease-causing alleles include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>(~80%) and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, frameshifts, intragenic and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions, and small deletions or insertions. The majority of missense variants occur in the two evolutionary conserved domains, the N-terminal N-DC and C-terminal C-DC domains [<a class="bk_pop" href="#dcx.REF.gleeson.1999.146">Gleeson et al 1999</a>, <a class="bk_pop" href="#dcx.REF.sapir.2000.703">Sapir et al 2000</a>, <a class="bk_pop" href="#dcx.REF.leger.2008.277">Leger et al 2008</a>].</p><p>Hot spot variants, observed multiple times, account for more than one third of identified sequence variants: p.Arg39Ter, p.Arg303Ter, p.Arg78Cys, p.Arg78His, p.Arg78Leu, p.Arg192Trp, p.Arg186Cys, p.Arg186His, p.Arg186Leu [<a class="bk_pop" href="#dcx.REF.bahibuisson.2013.223">Bahi-Buisson et al 2013</a>].</p><p>To date, males with lissencephaly resulting from a constitutional <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>DCX</i> whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or hemizygous <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant appear to be extremely rare, suggesting that <i>DCX</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants are likely lethal [<a class="bk_pop" href="#dcx.REF.haverfield.2009.911">Haverfield et al 2009</a>, <a class="bk_pop" href="#dcx.REF.leger.2008.277">Leger et al 2008</a>].</p><p>Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> is a frequent finding in <i>DCX</i>-related SBH. The detection rate for mosaicism depends on the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing method used and will further increase with widespread use of <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a> methodology [<a class="bk_pop" href="#dcx.REF.jamuar.2014.733">Jamuar et al 2014</a>]. Due to the sensitivity of current technologies, the proportion of <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> in both <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and parents for deletions or duplications may be underestimated.</p><p>In females with two X chromosomes, <i>DCX</i> pathogenic variants may not result in characteristic clinical features. To the authors' knowledge, sex-<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> aneuploidies (e.g., 45,X or 47,XXX or 47,XXY) have not to date been associated with <i>DCX</i>-related disorders.</p><div id="dcx.T.dcx_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>DCX</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1185/table/dcx.T.dcx_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dcx.T.dcx_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.115C&#x0003e;T</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg39Ter</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_3" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_178153.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_178153<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_835366.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_835366<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.232C&#x0003e;T</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg78Cys</td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.233G&#x0003e;A</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg78His</td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.233G&#x0003e;T</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg78Leu</td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.556C&#x0003e;T</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186Cys</td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.557G&#x0003e;A</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186His</td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.557G&#x0003e;T</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186Leu</td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.574C&#x0003e;T</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg192Trp</td></tr><tr><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.907C&#x0003e;T</td><td headers="hd_h_dcx.T.dcx_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg303Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Neuronal migration protein doublecortin (DCX) is a microtubule-binding protein containing two in-tandem-organized microtubule-binding domains, in the so-called DCX <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, not previously described in other microtubule-associated proteins (MAPs). Microtubules constitute a central element of the cytoskeleton and as such play a crucial role in many cellular processes such as cell division, cell migration, and maintenance of cellular morphology. In vitro, DCX can promote microtubule polymerization and stabilization of the microtubules.</p><p>DCX associates with the 13-protofilaments microtubules to stabilize them and can even override the nucleotide dependence of microtubule polymerization [<a class="bk_pop" href="#dcx.REF.moores.2006.4448">Moores et al 2006</a>, <a class="bk_pop" href="#dcx.REF.fourniol.2010.463">Fourniol et al 2010</a>]. DCX is particularly enriched at the end neuronal processes where microtubules enter the growth cone [<a class="bk_pop" href="#dcx.REF.friocourt.2003.620">Friocourt et al 2003</a>]. DCX also appears to be enriched in axonal regions capable of generating collaterals [<a class="bk_pop" href="#dcx.REF.tint.2009.10995">Tint et al 2009</a>]. Therefore, DCX is thought to promote elongation and stabilization of the microtubule network during process outgrowth. Moreover, DCX could also be involved in the somal <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> occurring during neuroblast migration and influence the course of neuroblast proliferation.</p><p>DCX is a phosphoprotein that can be a substrate for several protein kinases including JNK, PKA, MARK, and Cdk5. Phosphorylation of DCX alters its interaction with microtubules and thereby possibly its function. The impact of DCX phosphorylation on its reported interaction with other proteins, such as LIS1, neurabin II, or clathrin-associated protein &#x000b5;1A, remains to be investigated.</p><p>More recently, <i>DCX</i> has also been shown to be expressed during embryonal development in motor neurons and skeletal muscle at the neuromuscular junctions with loss of DCX resulting in disturbed neuromuscular junction formation [<a class="bk_pop" href="#dcx.REF.bourgeois.2015.461">Bourgeois et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Abnormal DCX products may affect proper microtubule formation and perturb the mitotic machinery, although not all abnormal products appear to do so to the same extent [<a class="bk_pop" href="#dcx.REF.sapir.2000.703">Sapir et al 2000</a>, <a class="bk_pop" href="#dcx.REF.couillarddespres.2004.83">Couillard-Despres et al 2004</a>]. The effect of <i>DCX</i> pathogenic variants on protein function is therefore not yet fully understood. Functional studies indicate loss of function for several abnormal DCX products, which may however be mediated by different cellular or off-pathway mechanisms [<a class="bk_pop" href="#dcx.REF.yap.2016.26613">Yap et al 2016</a>].</p></div></div><div id="dcx.References"><h2 id="_dcx_References_">References</h2><div id="dcx.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.aigner.2003.329">Aigner L, Uyanik G, Couillard-Despres S, Ploetz S, Wolff G, Morris-Rosendahl D, Martin P, Eckel U, Spranger S, Otte J, Woerle H, Holthausen H, Apheshiotis N, Fluegel D, Winkler J. Somatic mosaicism and variable penetrance in doublecortin-associated migration disorders. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:329–32.</span> [<a href="/pubmed/12552055" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12552055</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.bahibuisson.2014.1676">Bahi-Buisson N, Poirier K, Fourniol F, Saillour Y, Valence S, Lebrun N, Hully M, Bianco CF, Boddaert N, Elie C, Lascelles K, Souville I, Beldjord C, Chelly J, et al.  The wide spectrum of tubulinopathies: what are the key features for the diagnosis? <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:1676–700.</span> [<a href="/pubmed/24860126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24860126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.bahibuisson.2013.223">Bahi-Buisson N, Souville I, Fourniol FJ, Toussaint A, Moores CA, Houdusse A, Lemaitre JY, Poirier K, Khalaf-Nazzal R, Hully M, Leger PL, Elie C, Boddaert N, Beldjord C, Chelly J, Francis F, et al.  New insights into genotype-phenotype correlations for the double cortin-related lissencephaly spectrum. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:223–44.</span> [<a href="/pmc/articles/PMC3562079/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3562079</span></a>] [<a href="/pubmed/23365099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23365099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.bernasconi.2001.1124">Bernasconi A, Martinez V, Rosa-Neto P, D'Agostino D, Bernasconi N, Berkovic S, MacKay M, Harvey AS, Palmini A, da Costa JC, Paglioli E, Kim HI, Connolly M, Olivier A, Dubeau F, Andermann E, Guerrini R, Whisler W, de Toledo-Morrell L, Morrell F, Andermann F. Surgical resection for intractable epilepsy in "double cortex" syndrome yields inadequate results. <span><span class="ref-journal">Epilepsia. </span>2001;<span class="ref-vol">42</span>:1124–9.</span> [<a href="/pubmed/11580758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11580758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.bourgeois.2015.461">Bourgeois F, Mess&#x000e9;ant J, Kordeli E, Petit JM, Delers P, Bahi-Buisson N, Bernard V, Sigoillot SM, Gitiaux C, Stouffer M, Francis F, Legay C. A critical and previously unsuspected role for doublecortin at the neuromuscular junction in mouse and human. <span><span class="ref-journal">Neuromuscul Disord. </span>2015;<span class="ref-vol">25</span>:461–73.</span> [<a href="/pubmed/25817838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25817838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.bruno.2010.299">Bruno DL, Anderlid BM, Lindstrand A, van Ravenswaaij-Arts C, Ganesamoorthy D, Lundin J, Martin CL, Douglas J, Nowak C, Adam MP, Kooy RF, Van der Aa N, Reyniers E, Vandeweyer G, Stolte-Dijkstra I, Dijkhuizen T, Yeung A, Delatycki M, Borgstr&#x000f6;m B, Thelin L, Cardoso C, van Bon B, Pfundt R, de Vries BB, Wallin A, Amor DJ, James PA, Slater HR, Schoumans J. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:299–311.</span> [<a href="/pubmed/20452996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20452996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.coman.2017">Coman D, Fullston T, Shoubridge C, Leventer R, Wong F, Nazaretian S, Simpson I, Gecz J, McGillivray G. X-linked lissencephaly with absent corpus callosum and abnormal genitalia: an evolving multisystem syndrome with severe congenital intestinal diarrhea disease. Child Neurol Open. 2017;4:2329048X17738625. [<a href="/pmc/articles/PMC5680935/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5680935</span></a>] [<a href="/pubmed/29152528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29152528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.couillarddespres.2004.83">Couillard-Despres S, Uyanik G, Ploetz S, Karl C, Koch H, Winkler J, Aigner L. Mitotic impairment by doublecortin is diminished by doublecortin mutations found in patients. <span><span class="ref-journal">Neurogenetics. </span>2004;<span class="ref-vol">5</span>:83–93.</span> [<a href="/pubmed/15045646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15045646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.dagostino.2002.2507">D'Agostino MD, Bernasconi A, Das S, Bastos A, Valerio RM, Palmini A, Costa da Costa J, Scheffer IE, Berkovic S, Guerrini R, Dravet C, Ono J, Gigli G, Federico A, Booth F, Bernardi B, Volpi L, Tassinari CA, Guggenheim MA, Ledbetter DH, Gleeson JG, Lopes-Cendes I, Vossler DG, Malaspina E, Franzoni E, Sartori RJ, Mitchell MH, Mercho S, Dubeau F, Andermann F, Dobyns WB, Andermann E. Subcortical band heterotopia (SBH) in males: clinical, imaging and genetic findings in comparison with females. <span><span class="ref-journal">Brain. </span>2002;<span class="ref-vol">125</span>:2507–22.</span> [<a href="/pubmed/12390976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12390976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.demelas.2001.327">Demelas L, Serra G, Conti M, Achene A, Mastropaolo C, Matsumoto N, Dudlicek LL, Mills PL, Dobyns WB, Ledbetter DH, Das S. Incomplete penetrance with normal MRI in a woman with germline mutation of the DCX gene. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">57</span>:327–30.</span> [<a href="/pubmed/11468322" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11468322</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.des_portes.1998.51">des Portes V, Pinard JM, Billuart P, Vinet MC, Koulakoff A, Carrie A, Gelot A, Dupuis E, Motte J, Berwald-Netter Y, Catala M, Kahn A, Beldjord C, Chelly J. A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. <span><span class="ref-journal">Cell. </span>1998;<span class="ref-vol">92</span>:51–61.</span> [<a href="/pubmed/9489699" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9489699</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.di_donato.2017.1473">Di Donato N, Chiari S, Mirzaa GM, Aldinger K, Parrini E, Olds C, Barkovich AJ, Guerrini R, Dobyns WB. Lissencephaly: expanded imaging and clinical classification. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:1473–88.</span> [<a href="/pmc/articles/PMC5526446/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5526446</span></a>] [<a href="/pubmed/28440899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28440899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.di_donato.2016a.1117">Di Donato N, Jean YY, Maga AM, Krewson BD, Shupp AB, Avrutsky MI, Roy A, Collins S, Olds C, Willert RA, Czaja AM, Johnson R, Stover JA, Gottlieb S, Bartholdi D, Rauch A, Goldstein A, Boyd-Kyle V, Aldinger KA, Mirzaa GM, Nissen A, Brigatti KW, Puffenberger EG, Millen KJ, Strauss KA, Dobyns WB, Troy CM, Jinks RN. Mutations in CRADD result in reduced caspase-2-mediated neuronal apoptosis and cause megalencephaly with a rare lissencephaly variant. <span><span class="ref-journal">Am J Hum Genet. </span>2016a;<span class="ref-vol">99</span>:1117–29.</span> [<a href="/pmc/articles/PMC5097945/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5097945</span></a>] [<a href="/pubmed/27773430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27773430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.di_donato.2016b.2644">Di Donato N, Kuechler A, Vergano S, Heinritz W, Bodurtha J, Merchant SR, Breningstall G, Ladda R, Sell S, Altm&#x000fc;ller J, B&#x000f6;gershausen N, Timms AE, Hackmann K, Schrock E, Collins S, Olds C, Rump A, Dobyns WB. Update on the ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2016b;<span class="ref-vol">170</span>:2644–51.</span> [<a href="/pubmed/27240540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27240540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.dobyns.2010.5">Dobyns WB. The clinical patterns and molecular genetics of lissencephaly and subcortical band heterotopia. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span> Suppl 1:5–9.</span> [<a href="/pubmed/20331703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20331703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.forman.2005.847">Forman MS, Squier W, Dobyns WB, Golden JA. Genotypically defined lissencephalies show distinct pathologies. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2005;<span class="ref-vol">64</span>:847–57.</span> [<a href="/pubmed/16215456" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16215456</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.fourniol.2010.463">Fourniol FJ, Sindelar CV, Amigues B, Clare DK, Thomas G, Perderiset M, Francis F, Houdusse A, Moores CA. Template-free 13-protofilament microtubule-MAP assembly visualized at 8 A resolution. <span><span class="ref-journal">J Cell Biol. </span>2010;<span class="ref-vol">191</span>:463–70.</span> [<a href="/pmc/articles/PMC3003314/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3003314</span></a>] [<a href="/pubmed/20974813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20974813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.franco.2016.426">Franco A, Pimentel J, Campos AR, Morgado C, Pinelo S, Ferreira AG, Bentes C. Stimulation of the bilateral anterior nuclei of the thalamus in the treatment of refractory epilepsy: two cases of subcortical band heterotopia. <span><span class="ref-journal">Epileptic Disord. </span>2016;<span class="ref-vol">18</span>:426–30.</span> [<a href="/pubmed/27965181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27965181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.friocourt.2003.620">Friocourt G, Koulakoff A, Chafey P, Boucher D, Fauchereau F, Chelly J, Francis F. Doublecortin functions at the extremities of growing neuronal processes. <span><span class="ref-journal">Cereb Cortex. </span>2003;<span class="ref-vol">13</span>:620–6.</span> [<a href="/pubmed/12764037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12764037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.ghai.2006.389">Ghai S, Fong KW, Toi A, Chitayat D, Pantazi S, Blaser S. Prenatal US and MR imaging findings of lissencephaly: review of fetal cerebral sulcal development. <span><span class="ref-journal">Radiographics. </span>2006;<span class="ref-vol">26</span>:389–405.</span> [<a href="/pubmed/16549605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16549605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.gleeson.1998.63">Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, Walsh CA. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. <span><span class="ref-journal">Cell. </span>1998;<span class="ref-vol">92</span>:63–72.</span> [<a href="/pubmed/9489700" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9489700</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.gleeson.2000.574">Gleeson JG, Minnerath S, Kuzniecky RI, Dobyns WB, Young ID, Ross ME, Walsh CA. Somatic and germline mosaic mutations in the doublecortin gene are associated with variable phenotypes. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:574–81.</span> [<a href="/pmc/articles/PMC1287517/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1287517</span></a>] [<a href="/pubmed/10915612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10915612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.gleeson.1999.146">Gleeson JG, Minnerath SR, Fox JW, Allen KM, Luo RF, Hong SE, Berg MJ, Kuzniecky R, Reitnauer PJ, Borgatti R, Mira AP, Guerrini R, Holmes GL, Rooney CM, Berkovic S, Scheffer I, Cooper EC, Ricci S, Cusmai R, Crawford TO, Leroy R, Andermann E, Wheless JW, Dobyns WB, Ross ME, Walsh CA. Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. <span><span class="ref-journal">Ann Neurol. </span>1999;<span class="ref-vol">45</span>:146–53.</span> [<a href="/pubmed/9989615" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9989615</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.gonz_lezmor_n.2017.e0185103">Gonz&#x000e1;lez-Mor&#x000f3;n D, Vishnopolska S, Consalvo D, Medina N, Marti M, C&#x000f3;rdoba M, Vazquez-Dusefante C, Claverie S, Rodr&#x000ed;guez-Quiroga SA, Vega P, Silva W, Kochen S, Kauffman MA. Germline and somatic mutations in cortical malformations: molecular defects in Argentinean patients with neuronal migration disorders. <span><span class="ref-journal">PLoS One. </span>2017;<span class="ref-vol">12</span>:e0185103.</span> [<a href="/pmc/articles/PMC5617183/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5617183</span></a>] [<a href="/pubmed/28953922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28953922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.guerrini.2005.287">Guerrini R, Filippi T. Neuronal migration disorders, genetics, and epileptogenesis. <span><span class="ref-journal">J Child Neurol. </span>2005;<span class="ref-vol">20</span>:287–99.</span> [<a href="/pubmed/15921228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15921228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.guerrini.2003.30">Guerrini R, Moro F, Andermann E, Hughes E, D'Agostino D, Carrozzo R, Bernasconi A, Flinter F, Parmeggiani L, Volzone A, Parrini E, Mei D, Jarosz JM, Morris RG, Pratt P, Tortorella G, Dubeau F, Andermann F, Dobyns WB, Das S. Nonsyndromic mental retardation and cryptogenic epilepsy in women with doublecortin gene mutations. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">54</span>:30–7.</span> [<a href="/pubmed/12838518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12838518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.haverfield.2009.911">Haverfield EV, Whited AJ, Petras KS, Dobyns WB, Das S. Intragenic deletions and duplications of the LIS1 and DCX genes: a major disease-causing mechanism in lissencephaly and subcortical band heterotopia. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:911–8.</span> [<a href="/pmc/articles/PMC2986498/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986498</span></a>] [<a href="/pubmed/19050731" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19050731</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.hoischen.2009.1673">Hoischen A, Landwehr C, Kabisch S, Ding XQ, Trost D, Stropahl G, Wigger M, Radlwimmer B, Weber RG, Haffner D. Array-CGH in unclear syndromic nephropathies identifies a microdeletion in Xq22.3-q23. <span><span class="ref-journal">Pediatr Nephrol. </span>2009;<span class="ref-vol">24</span>:1673–81.</span> [<a href="/pubmed/19444485" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19444485</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.jamuar.2014.733">Jamuar SS, Lam AT, Kircher M, D'Gama AM, Wang J, Barry BJ, Zhang X, Hill RS, Partlow JN, Rozzo A, Servattalab S, Mehta BK, Topcu M, Amrom D, Andermann E, Dan B, Parrini E, Guerrini R, Scheffer IE, Berkovic SF, Leventer RJ, Shen Y, Wu BL, Barkovich AJ, Sahin M, Chang BS, Bamshad M, Nickerson DA, Shendure J, Poduri A, Yu TW, Walsh CA. Somatic mutations in cerebral cortical malformations. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">371</span>:733–43.</span> [<a href="/pmc/articles/PMC4274952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4274952</span></a>] [<a href="/pubmed/25140959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25140959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.leger.2008.277">Leger PL, Souville I, Boddaert N, Elie C, Pinard JM, Plouin P, Moutard ML, des Portes V, Van Esch H, Joriot S, Renard JL, Chelly J, Francis F, Beldjord C, Bahi-Buisson N. The location of DCX mutations predicts malformation severity in X-linked lissencephaly. <span><span class="ref-journal">Neurogenetics. </span>2008;<span class="ref-vol">9</span>:277–85.</span> [<a href="/pubmed/18685874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18685874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.leventer.2005.307">Leventer RJ. Genotype-phenotype correlation in lissencephaly and subcortical band heterotopia: the key questions answered. <span><span class="ref-journal">J Child Neurol. </span>2005;<span class="ref-vol">20</span>:307–12.</span> [<a href="/pubmed/15921231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15921231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.magen.2015.305">Magen D, Ofir A, Berger L, Goldsher D, Eran A, Katib N, Nijem Y, Vlodavsky E, Tzur S, Behar DM, Fellig Y, Mandel H. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with a loss-of-function mutation in CDK5. <span><span class="ref-journal">Hum Genet. </span>2015;<span class="ref-vol">134</span>:305–14.</span> [<a href="/pubmed/25560765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25560765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.marcorelles.2010.503">Marcorelles P, Laquerri&#x000e8;re A, Adde-Michel C, Marret S, Saugier-Veber P, Beldjord C, Friocourt G. Evidence for tangential migration disturbances in human lissencephaly resulting from a defect in LIS1, DCX and ARX genes. <span><span class="ref-journal">Acta Neuropathol. </span>2010;<span class="ref-vol">120</span>:503–15.</span> [<a href="/pubmed/20461390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20461390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.martin.2004.108">Martin P, Uyanik G, Wiemer-Kruel A, Schneider S, Gross C, Hehr U, Winkler J. Different clinical and morphological phenotypes in monozygotic twins with identical DCX mutation. <span><span class="ref-journal">J Neurol. </span>2004;<span class="ref-vol">251</span>:108–10.</span> [<a href="/pubmed/14999500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14999500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.matsumoto.2001.5">Matsumoto N, Leventer RJ, Kuc JA, Mewborn SK, Dudlicek LL, Ramocki MB, Pilz DT, Mills PL, Das S, Ross ME, Ledbetter DH, Dobyns WB. Mutation analysis of the DCX gene and genotype/phenotype correlation in subcortical band heterotopia. <span><span class="ref-journal">Eur J Hum Genet. </span>2001;<span class="ref-vol">9</span>:5–12.</span> [<a href="/pubmed/11175293" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11175293</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.moores.2006.4448">Moores CA, Perderiset M, Kappeler C, Kain S, Drummond D, Perkins SJ, Chelly J, Cross R, Houdusse A, Francis F. Distinct roles of doublecortin modulating the microtubule cytoskeleton. <span><span class="ref-journal">EMBO J. </span>2006;<span class="ref-vol">25</span>:4448–57.</span> [<a href="/pmc/articles/PMC1590004/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1590004</span></a>] [<a href="/pubmed/16957770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16957770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.moreira.2015.62">Moreira I, Bastos-Ferreira R, Silva J, Ribeiro C, Alonso I, Chaves J. Paternal transmission of subcortical band heterotopia through DCX somatic mosaicism. <span><span class="ref-journal">Seizure. </span>2015;<span class="ref-vol">25</span>:62–4.</span> [<a href="/pubmed/25645638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25645638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.mutch.2016.528">Mutch CA, Poduri A, Sahin M, Barry B, Walsh CA, Barkovich AJ. Disorders of microtubule function in neurons: imaging correlates. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2016;<span class="ref-vol">37</span>:528–35.</span> [<a href="/pmc/articles/PMC4792764/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4792764</span></a>] [<a href="/pubmed/26564436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26564436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.pilz.1998.2029">Pilz DT, Matsumoto N, Minnerath S, Mills P, Gleeson JG, Allen KM, Walsh CA, Barkovich AJ, Dobyns WB, Ledbetter DH, Ross ME. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:2029–37.</span> [<a href="/pubmed/9817918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9817918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.poirier.2013.639">Poirier K, Lebrun N, Broix L, Tian G, Saillour Y, Boscheron C, Parrini E, Valence S, Pierre BS, Oger M, Lacombe D, Genevi&#x000e8;ve D, Fontana E, Darra F, Cances C, Barth M, Bonneau D, Bernadina BD, N'guyen S, Gitiaux C, Parent P, des Portes V, Pedespan JM, Legrez V, Castelnau-Ptakine L, Nitschke P, Hieu T, Masson C, Zelenika D, Andrieux A, Francis F, Guerrini R, Cowan NJ, Bahi-Buisson N, Chelly J. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. <span><span class="ref-journal">Nature Genet. </span>2013;<span class="ref-vol">45</span>:639–47.</span> [<a href="/pmc/articles/PMC3826256/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3826256</span></a>] [<a href="/pubmed/23603762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23603762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.qu_lin.2012.367">Qu&#x000e9;lin C, Saillour Y, Souville I, Poirier K, N'guyen-Morel MA, Vercueil L, Millisher-Bellaiche AE, Boddaert N, Dubois F, Chelly J, Beldjord C, Bahi-Buisson N. Mosaic DCX deletion causes subcortical band heterotopia in males. <span><span class="ref-journal">Neurogenetics. </span>2012;<span class="ref-vol">13</span>:367–73.</span> [<a href="/pubmed/22833188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22833188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.reiner.2006.188">Reiner O, Coquelle FM, Peter B, Levy T, Kaplan A, Sapir T, Orr I, Barkai N, Eichele G, Bergmann S. The evolving doublecortin (DCX) superfamily. <span><span class="ref-journal">BMC Genomics. </span>2006;<span class="ref-vol">7</span>:188.</span> [<a href="/pmc/articles/PMC1550402/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1550402</span></a>] [<a href="/pubmed/16869982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16869982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.sapir.2000.703">Sapir T, Horesh D, Caspi M, Atlas R, Burgess HA, Wolf SG, Francis F, Chelly J, Elbaum M, Pietrokovski S, Reiner O. Doublecortin mutations cluster in evolutionarily conserved functional domains. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:703–12.</span> [<a href="/pubmed/10749977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10749977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.taylor.2000.34442">Taylor KR, Holzer AK, Bazan JF, Walsh CA, Gleeson JG. Patient mutations in doublecortin define a repeated tubulin-binding domain. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:34442–50.</span> [<a href="/pubmed/10946000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10946000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.tint.2009.10995">Tint I, Jean D, Baas PW, Black MM. Doublecortin associates with microtubules preferentially in regions of the axon displaying actin-rich protrusive structures. <span><span class="ref-journal">J Neurosci. </span>2009;<span class="ref-vol">29</span>:10995–1010.</span> [<a href="/pmc/articles/PMC2757270/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2757270</span></a>] [<a href="/pubmed/19726658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19726658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.tsai.2016.788">Tsai MH, Kuo PW, Myers CT, Li SW, Lin WC, Fu TY, Chang HY, Mefford HC, Chang YC, Tsai JW. A novel DCX missense mutation in a family with X-linked lissencephaly and subcortical band heterotopia syndrome inherited from alow-level somatic mosaic mother: genetic and functional studies. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2016;<span class="ref-vol">20</span>:788–94.</span> [<a href="/pubmed/27292316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27292316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.uyanik.2003.232">Uyanik G, Aigner L, Martin P, Gross C, Neumann D, Marschner-Sch&#x000e4;fer H, Hehr U, Winkler J. ARX mutations in X-linked lissencephaly with abnormal genitalia. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:232–5.</span> [<a href="/pubmed/12874405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12874405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.uyanik.2007.442">Uyanik G, Morris-Rosendahl DJ, Stiegler J, Klapecki J, Gross C, Berman Y, Martin P, Dey L, Spranger S, Korenke GC, Schreyer I, Hertzberg C, Neumann TE, Burkart P, Spaich C, Meng M, Holthausen H, Ades L, Seidel J, Mangold E, Buyse G, Meinecke P, Schara U, Zeschnigk C, Muller D, Helland G, Schulze B, Wright ML, Kortge-Jung S, Hehr A, Bogdahn U, Schuierer G, Kohlhase J, Aigner L, Wolff G, Hehr U, Winkler J. Location and type of mutation in the LIS1 gene do not predict phenotypic severity. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">69</span>:442–7.</span> [<a href="/pubmed/17664403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17664403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.valence.2016.545">Valence S, Garel C, Barth M, Toutain A, Paris C, Amsallem D, Barthez MA, Mayer M, Rodriguez D, Burglen L. RELN and VLDLR mutations underlie two distinguishable clinico-radiological phenotypes. <span><span class="ref-journal">Clin Genet. </span>2016;<span class="ref-vol">90</span>:545–9.</span> [<a href="/pubmed/27000652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27000652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.wynshawboris.2010.823">Wynshaw-Boris A, Pramparo T, Youn YH, Hirotsune S. Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. <span><span class="ref-journal">Semin Cell Dev Biol. </span>2010;<span class="ref-vol">21</span>:823–30.</span> [<a href="/pmc/articles/PMC2967611/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2967611</span></a>] [<a href="/pubmed/20688183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20688183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dcx.REF.yap.2016.26613">Yap CC, Digilio L, McMahon L, Roszkowska M, Bott CJ, Kruczek K, Winckler B. Different doublecortin (DCX) patient alleles show distinct phenotypes in cultured neurons: evidence for divergent loss-of-function and "off-pathway" cellular mechanisms. <span><span class="ref-journal">J Biol Chem. </span>2016;<span class="ref-vol">291</span>:26613–26.</span> [<a href="/pmc/articles/PMC5207172/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5207172</span></a>] [<a href="/pubmed/27799303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27799303</span></a>]</div></li></ul></div></div><div id="dcx.Chapter_Notes"><h2 id="_dcx_Chapter_Notes_">Chapter Notes</h2><div id="dcx.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.humangenetik-regensburg.de/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.humangenetik-regensburg.de</a></p></div><div id="dcx.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 February 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 March 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 October 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>31 March 2006 (jw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1185</span><span class="label">PMID: <a href="/pubmed/20301364" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301364</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/abs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/depdc5-epilepsy/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1185&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1185/?report=reader">PubReader</a></li><li><a href="/books/NBK1185/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1185" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1185" style="display:none" title="Cite this Page"><div class="bk_tt">Hehr U, Uyanik G, Aigner L, et al. DCX-Related Disorders. 2007 Oct 19 [Updated 2019 Feb 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1185/pdf/Bookshelf_NBK1185.pdf">PDF version of this page</a> (706K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#dcx.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#dcx.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#dcx.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#dcx.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#dcx.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#dcx.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#dcx.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#dcx.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#dcx.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#dcx.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#dcx.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#dcx.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1641[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DCX</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1471412" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1471412" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1471412" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1471412" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28211668" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Haack T, Hayflick SJ, Hogarth P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301567" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robertson S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301752" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAFAH1B1</i>-Associated Lissencephaly/Subcortical Band Heterotopia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAFAH1B1</i>-Associated Lissencephaly/Subcortical Band Heterotopia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dobyns WB, Das S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301361" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLP1</i> Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLP1</i> Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wolf NI, van Spaendonk RML, Hobson GM, Kamholz J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301364" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301364" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04109e75f66d18aad4ef79">DCX-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">DCX-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:45:03-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89558DE03FAC8100000000093403BB&amp;ncbi_session=CE89558DE04109E1_2356SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1185%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1185&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1185/&amp;ncbi_pagename=DCX-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89558DE04109E1_2356SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>